An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
MedMen Enterprises Inc. (CSE: MMEN, OTCQX: MMNFF) has appointed Ana Bowman as Chief Financial Officer, effective February 22, 2022. She succeeds interim CFO Reece Fulgham, who will return to consulting. Bowman has extensive cannabis industry experience, having served as Vice President of Financial Reporting at Tilray Brands (NASDAQ: TLRY). MedMen operates across several states in the U.S. and offers a variety of cannabis products through its retail stores and loyalty program.
Positive
Appointment of experienced CFO Ana Bowman may enhance financial management.
Bowman's background at Tilray indicates strong industry expertise.
Negative
Reece Fulgham's departure as interim CFO may lead to transitional uncertainties.
LOS ANGELES--(BUSINESS WIRE)--
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced the appointment of Ana Bowman as Chief Financial Officer, effective February 22, 2022. Bowman succeeds outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners.
Bowman brings years of cannabis industry expertise, having served as Vice President of Financial Reporting and FP&A of Tilray Brands (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis lifestyle and consumer packaged goods company. Prior to joining Tilray, Bowman served as Corporate Controller of several publicly-traded U.S. registrants, following an exit from the world of big four public accounting.
“We are excited to have Ana join as our permanent CFO — bringing with her significant financial expertise from her time at Tilray and large public accounting and auditing firms, including Ernst & Young and Deloitte,” said Michael Serruya, MedMen’s Chairman and CEO. “We also want to thank Reece for stepping in as our interim CFO and wish him well in his future endeavors.”
ABOUT MEDMEN:
MedMen is a premier American cannabis retailer with an operational footprint in California, Nevada, Illinois, Arizona, Massachusetts, and Florida. MedMen offers a robust selection of high‐quality products, including MedMen‐owned brands MedMen Red and LuxLyte through its premium retail stores, proprietary delivery service, as well as curbside and in‐store pickup. MedMen Buds, an industry‐first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier, and happier. Learn more about MedMen at www.medmen.com.
Ana Bowman has been appointed as the new CFO of MedMen Enterprises, effective February 22, 2022.
What experience does Ana Bowman bring to MedMen?
Ana Bowman has extensive experience in the cannabis industry, previously serving as Vice President of Financial Reporting at Tilray Brands (NASDAQ: TLRY).
What are the stock symbols for MedMen and Tilray?
MedMen is traded as MMEN on CSE and MMNFF on OTCQX, while Tilray is traded as TLRY on NASDAQ.
What was the reason for Reece Fulgham's departure from MedMen?
Reece Fulgham served as interim CFO and will return to his consulting firm SierraConstellation Partners.
How does MedMen operate in the cannabis market?
MedMen is a leading cannabis retailer operating in several U.S. states, offering a range of high-quality cannabis products.
